Antibody-induced neutralization or use of recombinant A box domain of HMGB1 (antagonist of B box proinflammatory activity) in sepsis could improve the outcome, even when applied after the onset of disease [17, 47, 48]. Here, HMGB1 is linked to Sepsis.